Menu
GeneBe

11-36490598-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP2PP3

The NM_004620.4(TRAF6):c.809T>G(p.Met270Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.00061 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

TRAF6
NM_004620.4 missense

Scores

4
10
4

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.77
Variant links:
Genes affected
TRAF6 (HGNC:12036): (TNF receptor associated factor 6) The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from, members of the TNF receptor superfamily. This protein has an amino terminal RING domain which is followed by four zinc-finger motifs, a central coiled-coil region and a highly conserved carboxyl terminal domain, known as the TRAF-C domain and mediates signaling from members of the TNF receptor superfamily as well as the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. This protein also interacts with the transforming growth factor (TGF) beta receptor complex and is required for Smad-independent activation of the JNK and p38 kinases. The protein encoded by this gene is a key molecule in antiviral innate and antigen-specific immune responses. [provided by RefSeq, Nov 2021]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PP2
Missense variant where missense usually causes diseases, TRAF6
PP3
MetaRNN computational evidence supports a deleterious effect, 0.801

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TRAF6NM_004620.4 linkuse as main transcriptc.809T>G p.Met270Arg missense_variant 7/7 ENST00000526995.6
TRAF6NM_145803.3 linkuse as main transcriptc.809T>G p.Met270Arg missense_variant 8/8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TRAF6ENST00000526995.6 linkuse as main transcriptc.809T>G p.Met270Arg missense_variant 7/71 NM_004620.4 P1
TRAF6ENST00000348124.5 linkuse as main transcriptc.809T>G p.Met270Arg missense_variant 8/81 P1
TRAF6ENST00000529150.1 linkuse as main transcriptn.354T>G non_coding_transcript_exon_variant 4/45

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000605
AC:
881
AN:
1455326
Hom.:
0
Cov.:
30
AF XY:
0.000591
AC XY:
428
AN XY:
724284
show subpopulations
Gnomad4 AFR exome
AF:
0.000390
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.000151
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000735
Gnomad4 OTH exome
AF:
0.000582
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 14, 2023The c.809T>G (p.M270R) alteration is located in exon 8 (coding exon 6) of the TRAF6 gene. This alteration results from a T to G substitution at nucleotide position 809, causing the methionine (M) at amino acid position 270 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.24
D
BayesDel_noAF
Uncertain
0.10
Cadd
Uncertain
25
Dann
Uncertain
0.98
DEOGEN2
Uncertain
0.43
T;T
Eigen
Benign
0.19
Eigen_PC
Uncertain
0.33
FATHMM_MKL
Pathogenic
1.0
D
M_CAP
Benign
0.014
T
MetaRNN
Pathogenic
0.80
D;D
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.4
M;M
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.69
T
PROVEAN
Uncertain
-4.1
D;D
REVEL
Uncertain
0.43
Sift
Uncertain
0.0020
D;D
Sift4G
Uncertain
0.0020
D;D
Polyphen
0.075
B;B
Vest4
0.91
MutPred
0.41
Gain of MoRF binding (P = 0.0532);Gain of MoRF binding (P = 0.0532);
MVP
0.84
MPC
1.2
ClinPred
0.99
D
GERP RS
5.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.90
gMVP
0.97

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr11-36512148; API